Our Perspective

  • Bringing Big Data Under Control

    By Sabine Fahrig |December 18, 2013|English

    Big Data promises to make a huge difference to insurance companies in the context of marketing, underwriting and claims management. Today, capturing, storing and harnessing huge volumes of personal data on clients has become a priority, especially for...

    Read More
  • How Life Carriers Are Harnessing Big Data

    By Louis Rossouw |December 16, 2013|English

    Nowadays life insurance companies are starting to gain value from Big Data and are moving beyond using it for purely actuarial purposes - they are using it for modelling other policyholder behaviors, such as cross-selling rates, price elasticity and...

    Read More
  • Matters of Life and Death in Central America

    By Sara Goldberg |December 12, 2013|English

    Insurance penetration (premiums as a percentage of gross domestic product) is particularly low in Latin America, even for developing economies. But life insurance is growing more quickly in Latin America than anywhere else, apart from South and East...

    Read More
  • Fraud - A Fact of Life Insurance

    By Steve Mannik|December 02, 2013|English

    Fraud will always be present in the life insurance marketplace. Innovative and increasingly sophisticated scams mean that insurers have to constantly improve their processes and find new tools to help them fight false claims. Some fraud schemes read...

    Read More
  • How Our Research Works For You

    By Marcy Updike|November 09, 2013|English

    Interested in learning how to gain insights into Disability and Group Life insurance market trends? A unique service delivered through our Research Center - our MarketCheck survey series - is focused on providing just that. Designed to help our Disability...

    Read More
  • Measuring Mortality Risk for Hodgkin’s Lymphoma

    By Mary Murphy|October 10, 2013|English

    Hodgkin’s lymphoma (HL), formerly called Hodgkin’s disease, is a B-cell lymphoma that’s classified by the World Health Organization into one of five subtypes. The most common is nodular sclerosing, which accounts for 65% of HL in...

    Read More